Population Pharmacokinetics of Galcanezumab, an Anti‐CGRP Antibody, Following Subcutaneous Dosing to Healthy Individuals and Patients With Migraine

Galcanezumab is a humanized immunoglobulin G (IgG) monoclonal antibody (mAb) indicated for the prevention of migraine that binds to calcitonin gene‐related peptide. A population pharmacokinetic (PK) analysis was performed to characterize galcanezumab PK using data pooled from 7 clinical studies. Cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Kielbasa, William, Quinlan, Tonya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Pharmacometrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972493/
https://www.ncbi.nlm.nih.gov/pubmed/31482569
http://dx.doi.org/10.1002/jcph.1511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972493/
https://www.ncbi.nlm.nih.gov/pubmed/31482569
http://dx.doi.org/10.1002/jcph.1511

Ejemplares similares